Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.31B | 2.27B | 2.45B | 2.36B | 3.02B | Gross Profit |
205.57M | 333.99M | 396.46M | 407.59M | 399.38M | EBIT |
-55.22M | 2.89M | 108.49M | 180.30M | 134.66M | EBITDA |
22.89M | 74.44M | 173.34M | 225.00M | 176.68M | Net Income Common Stockholders |
-48.73M | 1.09M | 79.79M | 137.26M | 110.98M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
448.68M | 549.06M | 605.03M | 1.04B | 777.35M | Total Assets |
1.96B | 2.08B | 3.16B | 3.16B | 2.79B | Total Debt |
61.41M | 72.99M | 86.56M | 20.32M | 84.53M | Net Debt |
-286.19M | -352.16M | -400.21M | -903.50M | -621.55M | Total Liabilities |
583.32M | 644.60M | 1.71B | 1.92B | 1.70B | Stockholders Equity |
1.37B | 1.44B | 1.45B | 1.25B | 1.09B |
Cash Flow | Free Cash Flow | |||
-119.85M | -48.76M | -382.55M | 277.20M | 55.62M | Operating Cash Flow |
-41.42M | 26.14M | -294.02M | 348.03M | 84.84M | Investing Cash Flow |
-7.40M | -53.16M | -233.33M | -67.64M | -40.08M | Financing Cash Flow |
-22.65M | -23.00M | 87.50M | -66.61M | 47.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $487.19B | 34.38 | 27.96% | 2.42% | 19.20% | 24.01% | |
70 Outperform | $132.49B | 23.20 | 9.72% | 4.94% | -2.63% | -5.90% | |
69 Neutral | HK$62.53B | 6.51 | 17.64% | 7.63% | 10.46% | 5.94% | |
66 Neutral | €853.79B | 5.53 | 19.25% | 8.06% | 5.62% | -0.74% | |
64 Neutral | $4.36B | 12.05 | 5.23% | 249.94% | 4.13% | -10.23% | |
51 Neutral | $12.11B | ― | -10.34% | 9.80% | -56.64% | -3398.20% | |
46 Neutral | HK$96.36M | ― | -0.21% | ― | -22.84% | -103.13% |